82 related articles for article (PubMed ID: 15589835)
1. Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with integration.
Boese A; Sommer P; Gaussin A; Reimann A; Nehrbass U
FEBS Lett; 2004 Dec; 578(3):291-6. PubMed ID: 15589835
[TBL] [Abstract][Full Text] [Related]
2. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
[TBL] [Abstract][Full Text] [Related]
3. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
Craig E; Zhang ZK; Davies KP; Kalpana GV
EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication.
Turelli P; Doucas V; Craig E; Mangeat B; Klages N; Evans R; Kalpana G; Trono D
Mol Cell; 2001 Jun; 7(6):1245-54. PubMed ID: 11430827
[TBL] [Abstract][Full Text] [Related]
5. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
[TBL] [Abstract][Full Text] [Related]
6. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
[TBL] [Abstract][Full Text] [Related]
7. Integrase interactor 1 in health and disease.
Das S
Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
[TBL] [Abstract][Full Text] [Related]
8. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
[TBL] [Abstract][Full Text] [Related]
9. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
Versteege I; Medjkane S; Rouillard D; Delattre O
Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
[TBL] [Abstract][Full Text] [Related]
11. hSNF5 /INI1 mutation analysis in acute myeloid leukemia.
Su YC; Chen CB; Chang YT; Tung YT; Li DK
Int J Hematol; 2008 Mar; 87(2):172-175. PubMed ID: 18266055
[TBL] [Abstract][Full Text] [Related]
12. Generation of a monoclonal antibody for INI1/hSNF5/BAF47.
Harada A; Hayashi M; Kuniyoshi Y; Semba Y; Sugahara S; Tachibana T; Ohkawa Y; Fujita M
Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):49-51. PubMed ID: 24555937
[TBL] [Abstract][Full Text] [Related]
13. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
Lee D; Sohn H; Kalpana GV; Choe J
Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
Medjkane S; Novikov E; Versteege I; Delattre O
Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
[TBL] [Abstract][Full Text] [Related]
15. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.
Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S
Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367
[TBL] [Abstract][Full Text] [Related]
16. HIV integration. Ini1 for integration?
Miller MD; Bushman FD
Curr Biol; 1995 Apr; 5(4):368-70. PubMed ID: 7627549
[TBL] [Abstract][Full Text] [Related]
17. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
Albanese P; Belin MF; Delattre O
Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
[TBL] [Abstract][Full Text] [Related]
18. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.
Das S; Cano J; Kalpana GV
J Biol Chem; 2009 Jul; 284(30):19903-14. PubMed ID: 19398554
[TBL] [Abstract][Full Text] [Related]
19. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
[TBL] [Abstract][Full Text] [Related]
20. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
Day PM; Baker CC; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14252-7. PubMed ID: 15383670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
